Grand Pharmaceutical Group Limited (HKG: 0512)

Grand Pharmaceutical Group Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 6, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	15,163	14,394	16,225	22,930	24,421	14,321
Market Cap Growth	4.68%	-11.29%	-29.24%	-6.10%	70.53%	27.61%
Enterprise Value	16,677	16,581	18,124	22,786	25,877	15,983
Last Close Price	4.33	3.88	4.23	5.78	6.08	3.68
PE Ratio	6.28	7.24	7.21	8.54	11.68	10.69
PS Ratio	1.43	1.37	1.70	2.67	3.84	2.17
PB Ratio	0.97	0.94	1.14	1.71	2.15	1.68
P/FCF Ratio	-	7.43	13.34	14.95	19.58	19.41
P/OCF Ratio	-	5.94	8.81	11.43	16.77	10.98
EV/Sales Ratio	1.58	1.57	1.90	2.65	4.07	2.43
EV/EBITDA Ratio	4.93	5.16	5.83	9.14	12.59	8.52
EV/EBIT Ratio	5.49	5.80	6.59	10.50	14.51	11.34
EV/FCF Ratio	-	8.56	14.90	14.85	20.75	21.66
Debt / Equity Ratio	0.29	0.22	0.32	0.27	0.22	0.25
Debt / EBITDA Ratio	1.35	1.05	1.42	1.46	1.18	1.11
Debt / FCF Ratio	-	1.76	3.68	2.38	1.96	2.85
Asset Turnover	0.45	0.47	0.44	0.45	0.41	0.48
Inventory Turnover	3.62	2.94	2.94	3.23	2.62	3.22
Quick Ratio	1.08	0.98	0.86	1.00	1.00	0.75
Current Ratio	1.29	1.22	1.07	1.22	1.24	1.06
Return on Equity (ROE)	15.93%	12.86%	15.18%	19.41%	17.94%	14.12%
Return on Assets (ROA)	8.02%	7.96%	7.91%	7.13%	7.24%	6.45%
Return on Capital (ROIC)	9.67%	9.57%	9.60%	8.78%	9.13%	8.51%
Earnings Yield	15.92%	13.06%	12.82%	10.48%	7.34%	8.04%
FCF Yield	13.46%	7.50%	6.69%	5.11%	5.15%
Dividend Yield	5.86%	6.70%	3.31%	1.90%	1.81%	2.61%
Payout Ratio	0.00%	26.43%	18.78%	16.25%	18.09%	25.24%
Buyback Yield / Dilution	1.51%	0.97%	0.16%	-2.98%	-2.19%	-20.79%
Total Shareholder Return	7.37%	7.68%	3.47%	-1.08%	-0.38%	-18.18%

Source: S&P Capital IQ. Standard template. Financial Sources.